What is the treatment for trichomoniasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Trichomoniasis

The recommended first-line treatment for trichomoniasis is metronidazole 2g orally in a single dose, which achieves cure rates of approximately 90-95%. 1, 2

First-Line Treatment Options

  • Metronidazole 2g orally in a single dose is the preferred treatment regimen for trichomoniasis, with high efficacy rates 3, 1
  • An alternative regimen is metronidazole 500mg orally twice daily for 7 days, which may be more effective but requires longer treatment duration 3, 4
  • Recent research suggests that the 7-day regimen may have higher cure rates (89% vs 81%) compared to the single-dose regimen 4

Management of Sexual Partners

  • All sexual partners should be treated simultaneously to prevent reinfection, as trichomoniasis is a sexually transmitted disease 3, 1
  • Patients should abstain from sexual activity until both they and their partners complete treatment and are asymptomatic 1, 5
  • Treating asymptomatic partners is essential as they can serve as reservoirs for reinfection 2

Follow-Up Recommendations

  • Routine follow-up is unnecessary for patients who become asymptomatic after treatment 3, 1
  • If symptoms persist after initial treatment, patients should be re-evaluated for potential reinfection or treatment failure 3, 5

Treatment Failure Management

  • For first treatment failure, re-treat with metronidazole 500mg twice daily for 7 days 3
  • For repeated failure, administer metronidazole 2g once daily for 3-5 days 3, 1
  • If treatment continues to fail and reinfection has been excluded, consultation with an infectious disease specialist is recommended 3, 5
  • Consider susceptibility testing of T. vaginalis to metronidazole in cases of persistent infection 3

Special Populations

Pregnancy

  • Metronidazole is contraindicated during the first trimester of pregnancy 3, 5
  • After the first trimester, pregnant women can be treated with metronidazole 2g orally in a single dose 3
  • Treatment is important as trichomoniasis has been associated with adverse pregnancy outcomes, including premature rupture of membranes and preterm delivery 3, 5

HIV Infection

  • Patients with HIV infection should receive the same treatment regimen as HIV-negative individuals 3, 1

Metronidazole Allergy

  • For patients with true metronidazole allergy, options are limited as effective alternatives are not readily available 3, 6
  • Desensitization may be required in these cases 1, 6

Important Clinical Considerations

  • Topical metronidazole gel is NOT effective for trichomoniasis (efficacy <50%) and should not be used 1, 7
  • Metronidazole can cause a disulfiram-like reaction when combined with alcohol, including nausea, vomiting, flushing, headache, and abdominal cramps 1
  • Patients should be advised to avoid alcohol during treatment and for at least 24 hours after completing metronidazole therapy 1
  • Secnidazole (2g single dose) has recently been approved as an alternative treatment option with favorable pharmacokinetics and good tolerability 8
  • Tinidazole is also FDA-approved for trichomoniasis treatment and may be considered as an alternative 9

Treatment Algorithm

  1. First-line: Metronidazole 2g orally in a single dose 3, 1
  2. Alternative: Metronidazole 500mg orally twice daily for 7 days (consider when adherence is not a concern) 3, 4
  3. For treatment failure: Metronidazole 500mg twice daily for 7 days 3
  4. For repeated failure: Metronidazole 2g once daily for 3-5 days 3, 1
  5. For persistent infection: Consult infectious disease specialist and consider susceptibility testing 3, 5

References

Guideline

Trichomonas Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Trichomoniasis Vaginal Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Trichomoniasis in Patients with Azole Allergies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Secnidazole: a treatment for trichomoniasis in adolescents and adults.

Expert review of anti-infective therapy, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.